Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention

被引：0
|
作者：
Carlo Lovati
Gianna Bernasconi
Chiara Capogrosso
Laura Molteni
Federica Giorgetti
Bernardo Dell’Osso
Leonardo Pantoni
机构：
[1] L. Sacco University Hospital,Headache Center
[2] University of Monza,School of Medicine and Surgery
[3] L. Sacco University Hospital,Department of Mental Health
[4] University of Milan,L. Sacco Department of Biomedical and Clinical Sciences
[5] University of Milan,undefined
来源：
Neurological Sciences | 2022年 / 43卷
关键词：
CGRP; Personality Traits; Migraine; Erenumab; Galcanezumab; Fremanezumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5765 / 5767
页数：2
相关论文
共 50 条
  • [1] Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention
    Lovati, Carlo
    Bernasconi, Gianna
    Capogrosso, Chiara
    Molteni, Laura
    Giorgetti, Federica
    Dell'Osso, Bernardo
    Pantoni, Leonardo
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5765 - 5767
  • [2] Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
    Amy R. Tso
    Peter J. Goadsby
    Current Treatment Options in Neurology, 2017, 19
  • [3] Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
    Tso, Amy R.
    Goadsby, Peter J.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2017, 19 (08)
  • [4] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Fred Cohen
    Hsiangkuo Yuan
    E. M. G. DePoy
    Stephen D. Silberstein
    Neurotherapeutics, 2022, 19 : 922 - 930
  • [5] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Cohen, Fred
    Yuan, Hsiangkuo
    DePoy, E. M. G.
    Silberstein, Stephen D.
    NEUROTHERAPEUTICS, 2022, 19 (03) : 922 - 930
  • [6] Anti-CGRP monoclonal antibodies: migraine prevention in patients with psychiatric comorbidities
    di Cola, Francesca Schiano
    Ceccardi, Giulia
    Caratozzolo, Salvatore
    Bolchini, Marco
    Di Pasquale, Michele
    Rao, Renata
    Padovani, Alessandro
    CEPHALALGIA, 2023, 43 (1supp) : 252 - 253
  • [7] Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment
    Salim, Amira
    Najjar, Atia
    Ahmed, Zubair
    Mata, Ignacio
    NEUROLOGY, 2023, 100 (17)
  • [8] Anti-CGRP monoclonal antibodies in migraine: current perspectives
    Giamberardino, Maria Adele
    Affaitati, Giannapia
    Curto, Martina
    Negro, Andrea
    Costantini, Raffaele
    Martelletti, Paolo
    INTERNAL AND EMERGENCY MEDICINE, 2016, 11 (08) : 1045 - 1057
  • [9] Anti-CGRP monoclonal antibodies: breakthrough in migraine therapeutics
    Krishnaswamy, Ratna
    Malik, Bilal Haider
    Khan, Safeera
    Gupta, Deepti
    Islam, Muhammad
    Mandel, Shrawan Kumar
    Rutkofsky, Ian H.
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2019, 23 (03) : 26 - 33
  • [10] Placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention
    Regnier, S.
    Lee, X. Ying
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
12345